Stockscreener 앱 받기
1.79
2.99%
-0.05
전일 마감가:
$1.84
열려 있는:
$1.84
하루 거래량:
74,942
Relative Volume:
0.61
시가총액:
$77.97M
수익:
$51.13M
순이익/손실:
$-93.80M
주가수익비율:
-0.8027
EPS:
-2.23
순현금흐름:
$-129.10M
1주 성능:
-4.55%
1개월 성능:
-0.83%
6개월 성능:
+24.83%
1년 성능:
-50.14%
1일 변동 폭
$1.77
$1.86
1주일 범위
$1.72
$1.885
52주 변동 폭
$0.89
$4.0695
Repare Therapeutics Inc Stock (RPTX) Company Profile
명칭
Repare Therapeutics Inc
전화
(857) 412-7018
주소
7171 FREDERICK BANTING, SAINT-LAURENT, QC
RPTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
1.815 | 79.04M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.54 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.00 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-06-09 | 업그레이드 | Stifel | Hold → Buy |
| 2023-02-03 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-06 | 개시 | CapitalOne | Overweight |
| 2022-04-12 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-03-17 | 재개 | Goldman | Buy |
| 2021-09-23 | 개시 | Stifel | Buy |
| 2021-09-13 | 개시 | H.C. Wainwright | Buy |
| 2021-06-28 | 개시 | Guggenheim | Buy |
| 2021-03-01 | 개시 | Berenberg | Buy |
| 2020-10-28 | 개시 | Northland Capital | Outperform |
| 2020-07-14 | 개시 | Cowen | Outperform |
| 2020-07-14 | 개시 | Goldman | Neutral |
| 2020-07-14 | 개시 | Morgan Stanley | Overweight |
| 2020-07-14 | 개시 | Piper Sandler | Overweight |
모두보기
Repare Therapeutics Inc 주식(RPTX)의 최신 뉴스
Analyzing Repare Therapeutics Inc. with multi timeframe charts2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
How Repare Therapeutics Inc. stock compares to industry benchmarks2025 Market Outlook & Risk Managed Investment Strategies - newser.com
Is Repare Therapeutics Inc. stock near bottom after declineJuly 2025 Update & Fast Gain Swing Alerts - newser.com
Why Repare Therapeutics Inc. stock remains resilient2025 Retail Activity & Real-Time Stock Entry Alerts - newser.com
Candlestick signals on Repare Therapeutics Inc. stock todayGold Moves & Fast Exit and Entry Strategy Plans - newser.com
How to monitor Repare Therapeutics Inc. with trend dashboardsWeekly Stock Summary & Technical Buy Zone Confirmations - newser.com
Volume spikes in Repare Therapeutics Inc. stock – what they meanOptions Play & Long-Term Capital Growth Ideas - newser.com
Repare Therapeutics Inc. stock volume spike explainedJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Published on: 2025-11-01 00:17:06 - newser.com
Is Repare Therapeutics Inc. stock attractive for ETFs2025 Momentum Check & Weekly Sector Rotation Insights - newser.com
Repare Therapeutics (RPTX) Projected to Post Earnings on Thursday - MarketBeat
Real time scanner hits for Repare Therapeutics Inc. explained2025 Biggest Moves & Precise Entry and Exit Recommendations - newser.com
How to interpret RSI for Repare Therapeutics Inc. stockJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
Risk adjusted return profile for Repare Therapeutics Inc. analyzedJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Repare Therapeutics Inc. (RPTX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
HC Wainwright Issues Positive Outlook for RPTX Earnings - MarketBeat
Here's Why Repare Therapeutics (NASDAQ:RPTX) Must Use Its Cash Wisely - Yahoo Finance
Q3 EPS Forecast for Repare Therapeutics Increased by Analyst - Defense World
Repare Therapeutics Inc. (NASDAQ:RPTX) Receives Average Rating of "Hold" from Analysts - MarketBeat
Repare Therapeutics’ Promising Study on Advanced Solid Tumors: A Closer Look - MSN
Q1 Earnings Forecast for RPTX Issued By HC Wainwright - MarketBeat
Can Repare Therapeutics Inc. stock deliver sustainable ROEQuarterly Earnings Report & High Accuracy Buy Signal Tips - Fundação Cultural do Pará
Repare Therapeutics stock price target cut as H.C. Wainwright questions drug candidate - Investing.com Nigeria
Repare Therapeutics (NASDAQ:RPTX) Given New $3.00 Price Target at HC Wainwright - Defense World
HC Wainwright & Co. Maintains Repare Therapeutics (RPTX) Buy Recommendation - Nasdaq
RPTX Analyst Forecasts - Quiver Quantitative
HC Wainwright Has Lowered Expectations for Repare Therapeutics (NASDAQ:RPTX) Stock Price - MarketBeat
RPTX: Analyst Lowers Target Price While Maintaining Buy Rating | - GuruFocus
Can Repare Therapeutics Inc. stock beat analyst upgrades2025 Big Picture & Low Drawdown Investment Ideas - fcp.pa.gov.br
Repare Therapeutics Inc (RPTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.03%
0.32%
자본화:
|
볼륨(24시간):